A Q1 2023 Earnings — Agilent Technologies, Inc. Revenue & Financial Results | Market Cap Arena

AAgilent Technologies, Inc.

$33B

Q1 2023 Earnings

Healthcare Medical - Diagnostics & Research

Income Statement

Revenue

$1.8B+4.9% YoY

Gross Profit

$968M55.1% margin

Operating Income

$426M24.3% margin

Net Income

$352M20.0% margin

EPS (Diluted)

$1.19

QoQ Revenue Growth

-5.0%

Cash Flow

Operating Cash Flow

$296M

Free Cash Flow

$220M

Stock-Based Comp.

$44M

Balance Sheet

Total Assets

$10.9B

Total Liabilities

$5.3B

Stockholders' Equity

$5.6B

Cash & Equivalents

$1.3B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$1.8B	$1.7B	+4.9%
Gross Profit	$968M	$910M	+6.4%
Operating Income	$426M	$376M	+13.3%
Net Income	$352M	$283M	+24.4%

Revenue Segments

Life Sciences and Applied Markets

$1.0B59%

Agilent CrossLab

$381M22%

Diagnostics and Genomics

$342M19%

Geographic Segments

Americas

$687M39%

Asia Pacific

$613M35%

Europe

$456M26%